{
  "meta": {
    "title": "36_Sjogren_S_Syndrome_And_Scleroderma",
    "url": "https://brainandscalpel.vercel.app/36-sjogren-s-syndrome-and-scleroderma-859acd04.html",
    "scrapedAt": "2025-11-30T12:28:38.854Z"
  },
  "questions": [
    {
      "text": "What is the most common cause of secondary Sjogren's syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 2,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 3,
          "text": "Scleroderma"
        },
        {
          "id": 4,
          "text": "Primary biliary cirrhosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common cause of secondary Sj&ouml;gren&rsquo;s syndrome is<strong> rheumatoid arthritis.</strong></p>\n<p>Sj&ouml;gren's syndrome is a chronic <strong>autoimmune</strong> disorder that affects the lacrimal and salivary glands. It also affects other organ systems, such as lungs, kidneys, and nervous system. It is seen in association with:</p>\n<ul>\n<li>Rheumatoid arthritis</li>\n<li>Systemic lupus erythematosus</li>\n<li>Scleroderma</li>\n<li>Mixed connective tissue disease</li>\n<li>Primary biliary cirrhosis</li>\n<li>Vasculitis</li>\n<li>Chronic active hepatitis C</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1225",
      "difficulty": "medium"
    },
    {
      "text": "Which is the most common extraglandular manifestation seen in patients diagnosed with Sjogren's syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Primary biliary cirrhosis"
        },
        {
          "id": 2,
          "text": "Vasculitis"
        },
        {
          "id": 3,
          "text": "Arthritis"
        },
        {
          "id": 4,
          "text": "Renal tubular acidosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most common extraglandular manifestation seen in patients with Sj&ouml;gren&rsquo;s syndrome is <strong>arthritis</strong> or arthralgia.</p>\n<p>The extraglandular manifestations in Sj&ouml;gren&rsquo;s syndrome are:</p>\n<ul>\n<li><strong>Arthralgia</strong> or arthritis - most common manifestation. It is usually <strong>non-erosive</strong> and leads to <strong>Jaccoud's arthropathy.&nbsp;</strong>Jaccoud's arthropathy&nbsp;is a deforming&nbsp;non-erosive&nbsp;arthropathy characterized by the&nbsp;ulnar deviation&nbsp;of the second to 5<sup>th</sup>&nbsp;fingers with metacarpophalangeal joint subluxation.</li>\n<li>Raynaud's phenomenon</li>\n<li>Interstitial lung disease - most common type is non-specific interstitial pneumonia (<strong>NSIP</strong>)</li>\n<li>Renal tubular acidosis - <strong>Type 1</strong> (distal) RTA</li>\n<li>Primary biliary cirrhosis</li>\n<li>Lymphoma - MALToma</li>\n</ul>\n<p>The give&nbsp;X-ray shows Jaccoud's arthropathy:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/177185cae72145cebef0694fd856d852x462x600.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The given image shows a patient with Jaccoud's arthropathy of the hands:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ea29d5d4ed174da0a7adf294fa341693x986x732.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1226",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged woman presented with complaints of persistent dry eyes and dry mouth since past few months. On examination, dry mucous membranes, bilateral parotid region swelling, and conjunctivitis were noted. This condition is associated with which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "HLA-DR2"
        },
        {
          "id": 2,
          "text": "HLA-DR4"
        },
        {
          "id": 3,
          "text": "HLA-DR3"
        },
        {
          "id": 4,
          "text": "HLA-B27"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p2\">Dry eyes and dry mouth along with parotid swelling and conjunctivitis are suggestive of <strong>Sj&ouml;gren&rsquo;s&nbsp;syndrome.</strong>&nbsp;It is associated with&nbsp;<strong>HLA-DR3 </strong>allele.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>HLA allele</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>HLA DR2, HLA-DR3</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>HLA-DR3</td>\n<td>Sjogren's syndrome</td>\n</tr>\n<tr>\n<td>HLA-DR4</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>HLA-B27</td>\n<td>Seronegative arthritis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6197",
      "difficulty": "medium"
    },
    {
      "text": "A software engineer presented with complaints of dryness and itching of eyes on staring at his laptop screen. On examination, parotid swelling was noted and the test shown below was positive. The serology of this patient is likely to be positive for which of the following antibodies?",
      "choices": [
        {
          "id": 1,
          "text": "Anti topoisomerase"
        },
        {
          "id": 2,
          "text": "Anti centromere"
        },
        {
          "id": 3,
          "text": "Anti U1-RNP"
        },
        {
          "id": 4,
          "text": "Anti Ro/SS-A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario of dry eyes, parotid swelling, and a positive Schirmer test is suggestive of <strong>Sj&ouml;gren's syndrome. </strong>It is associated with<strong>&nbsp;anti-Ro/SS-A </strong>and<strong> anti-La/SS-B</strong>&nbsp;autoantibodies.</p>\n<p>The presence of anti-Ro/SS-A and anti-La/SS-B indicate extra glandular involvement and <strong>poor prognosis</strong>.</p>\n<p>Note:&nbsp;Anti-Ro and anti-La in <strong>SLE</strong> indicate a <strong>good prognosis</strong>, due to decreased risk of nephritis and vasculitis.</p><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d54558cf5d494b4f969a54453199ddbc.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6183",
      "difficulty": "easy"
    },
    {
      "text": "A 55-year-old woman presents with dry mouth, and difficulty swallowing solid food. Physical examination finds enlargement of her parotid glands along with marked dryness of her buccal mucosa. Laboratory examination finds the presence of both SS-A and SS-B antibodies. Which of the following statements is not true about this condition?",
      "choices": [
        {
          "id": 1,
          "text": "About 75% of patients have rheumatoid factor"
        },
        {
          "id": 2,
          "text": "Patients are at high risk for development of B-cell lymphomas"
        },
        {
          "id": 3,
          "text": "Glomerular lesions are common"
        },
        {
          "id": 4,
          "text": "Lacrimal gland is a major target for this disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>Sjogren's syndrome</strong>. In this condition, <strong>glomerular lesions</strong> are extremely<strong> rare.&nbsp;</strong></p>\n<p>Defects of tubular function, including renal tubular acidosis, uricosuria, and phosphaturia, are often seen and are associated <strong>histologically</strong> with <strong>tubulointerstitial nephritis</strong>.</p>\n<p><strong>Lacrimal </strong>and<strong> salivary glands</strong> are the <strong>major targets</strong> of this disease, while the&nbsp;respiratory and gastrointestinal tracts and the vagina&nbsp;may also be involved. The characteristic decrease in tears and saliva (<strong>sicca syndrome</strong>) is the result of <strong>lymphocytic infiltration </strong>and<strong> fibrosis </strong>of the lacrimal and salivary glands.&nbsp;The infiltrate contains predominantly activated<strong> CD4</strong><strong>+ </strong><strong>helper T cells </strong>and some<strong> B cells, </strong>including<strong> plasma cells.</strong></p>\n<p>Antibodies detected are:</p>\n<ul>\n<li><strong>Rheumatoid factor -</strong>&nbsp;seen in 75% of patients, whether or not coexisting rheumatoid arthritis is present</li>\n<li>Anti-nuclear antibodies <strong>(ANAs)</strong></li>\n<li><strong>SS-A (Ro) -&nbsp;</strong>associated with&nbsp;early disease onset, longer disease duration, and extra-glandular manifestations, such as cutaneous vasculitis and nephritis</li>\n<li><strong>SS-B (La)</strong></li>\n</ul>\n<p>These patients are at<strong> high risk </strong>for the development of<strong> B-cell lymphomas.&nbsp;</strong>About 60% of patients have another accompanying autoimmune disorder, such as rheumatoid arthritis, and these patients also have the symptoms and signs of that disorder.</p>\n<p><strong>Biopsy of the lip </strong>(to examine minor salivary glands) is essential for the <strong>diagnosis </strong>of Sj&ouml;gren's syndrome<strong>.</strong></p>\n<p>The image shows an enlargement of the salivary gland with intense lymphocytic and plasma cell infiltration with ductal epithelial hyperplasia in the salivary gland.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f14b28bf51124f3289fcb5a746bbcc2ex1280x1174.JPEG\" alt=\"Explanation Image\"><p>Note:&nbsp;Mikulicz syndrome&nbsp;is characterized&nbsp;by lacrimal and salivary gland enlargement from any cause, including sarcoidosis, lymphomas, and other tumors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5971",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old woman presented with complaints of thickening of her skin and the finding shown below. On workup, ANA was positive and immunofluorescence showed nucleolar pattern. What is the most common extracutaneous manifestation associated with her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Pulmonary fibrosis"
        },
        {
          "id": 2,
          "text": "Myositis"
        },
        {
          "id": 3,
          "text": "Scleroderma renal crisis"
        },
        {
          "id": 4,
          "text": "Raynaud's phenomenon"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image is suggestive of <strong>microstomia.</strong> The findings of skin thickening, <strong>microstomia</strong>, positive ANA, and immunofluorescence showing nucleolar pattern point towards a diagnosis of <strong>systemic sclerosis</strong>. The most common extracutaneous manifestation of systemic sclerosis (scleroderma) is<strong> Raynaud's phenomenon.</strong></p>\n<p>Raynaud's phenomenon is characterized by episodes of <strong>reversible vasoconstriction</strong> in the fingers and toes on exposure to <strong>cold</strong>. Rarely, it affects the lips, tip of the nose, and earlobes. These episodes classically occur in the following sequence:</p>\n<ul>\n<li>Affected part turning<strong> pale</strong>&nbsp;due to vasoconstriction.</li>\n<li><strong>Blue </strong>due to<strong>&nbsp;</strong>ischemia, often associated with numbness or pain.</li>\n<li>As blood flow returns, the area turns <strong>red</strong>&nbsp;with a burning sensation.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8467c02c823442868d464d175a7dcb4ax498x1345.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Pattern of nuclear body suggests the type of antibody present in patient’s serum.</h3><p>Five basic patterns of nuclear fluorescence is recognized for anti-nuclear antibodies:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Staining pattern</strong></td>\n<td><strong>Antigen</strong></td>\n</tr>\n<tr>\n<td>Homogenous or diffuse nuclear staining</td>\n<td>Antibodies to <strong>chromatin, histones, </strong>and occasionally<strong> double-stranded DNA</strong></td>\n</tr>\n<tr>\n<td>Rim or peripheral staining</td>\n<td>Antibodies <strong>to double-stranded DNA, </strong>and sometimes to <strong>nuclear envelope proteins</strong></td>\n</tr>\n<tr>\n<td>Speckled pattern</td>\n<td>\n<p>One of the most commonly observed patterns of fluorescence, the least specific.&nbsp;</p>\n<p>Antibodies to non-DNA nuclear constituents such as <strong>Sm antigen, ribonucleoprotein, and SS-A and SS-B reactive antigens</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>Nucleolar pattern</td>\n<td>\n<p>Few discrete spots of fluorescence within the nucleus and represent&nbsp;<strong>antibodies to RNA</strong>.</p>\n<p><strong>Seen in systemic sclerosis.</strong></p>\n</td>\n</tr>\n<tr>\n<td>Centromeric pattern</td>\n<td>\n<p>Seen in systemic sclerosis</p>\n<p>Often contain antibodies specific for centromeres, which give rise to this pattern.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/79cff1e8d6244910afe4f779bd0d86aax1280x4885.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0415bbcbc915465ca92c44c9f12378c3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6550",
      "difficulty": "medium"
    },
    {
      "text": "A 14-year-old girl has the pallor of extremities followed by pain and cyanosis on exposure to cold. Which of the following diseases is she likely to develop in the later stages of life?",
      "choices": [
        {
          "id": 1,
          "text": "Myasthenia gravis"
        },
        {
          "id": 2,
          "text": "Scleroderma"
        },
        {
          "id": 3,
          "text": "Mikulicz syndrome"
        },
        {
          "id": 4,
          "text": "Dermatomyositis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario suggests that the patient has&nbsp;<strong>Raynaud phenomenon</strong>, which is associated with the risk of developing&nbsp;<strong>scleroderma </strong>in later stages of life.</p>\n<p>Raynaud phenomenon&nbsp;is manifested as <strong>episodic vasoconstriction</strong> of the arteries and arterioles of the<strong> extremities</strong>, causing pallor of extremities followed by<strong> pain</strong> and<strong> cyanosis.</strong>&nbsp;It is seen in virtually all patients with<strong> systemic sclerosis </strong>or<strong> scleroderma </strong>and precedes other symptoms in<strong> 70% </strong>of cases.</p>\n<p>The image shows features of Raynaud's phenomenon.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/db06da13868c4bfab2f410614c57a112x498x1345.JPEG\" alt=\"Explanation Image\"><p>Systemic sclerosis is characterized by <strong>progressive fibrosis </strong>involving the skin, gastrointestinal tract, and other tissues. Fibrosis may be the result of the <strong>activation</strong> of <strong>fibroblasts</strong> by <strong>cytokines</strong> produced by T cells.</p>\n<p>Focal, and sometimes diffuse, subcutaneous calcifications may develop, especially in patients with CREST syndrome. The most ominous manifestation is <strong>malignant hypertension.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5972",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false about Raynaud’s phenomenon?",
      "choices": [
        {
          "id": 1,
          "text": "Secondary Raynaud’s is associated with more severe symptoms"
        },
        {
          "id": 2,
          "text": "Secondary Raynaud’s develops predominantly after the age of 30 years"
        },
        {
          "id": 3,
          "text": "Primary Raynaud's is usually ANA negative"
        },
        {
          "id": 4,
          "text": "Primary Raynaud’s is associated with digital tissue necrosis and ulcers"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Primary Raynaud's phenomenon is not associated with tissue necrosis and ulcers.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Primary Raynaud's phenomenon</strong></td>\n<td><strong>Secondary Raynaud's phenomenon</strong></td>\n</tr>\n<tr>\n<td>Age &amp; gender</td>\n<td>Young women (&lt;30y)</td>\n<td>Older women (&gt;30y)</td>\n</tr>\n<tr>\n<td>Associations</td>\n<td>No underlying cause</td>\n<td>Scleroderma, Sj&ouml;gren's syndrome and SLE</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>ANA test</td>\n<td>Negative</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>Severity - duration, frequency &amp; pain</td>\n<td>Less severe</td>\n<td>More severe</td>\n</tr>\n<tr>\n<td>Digital tissue necrosis, ulceration &amp; gangrene</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>\n<p>Nailfold capillaroscopy</p>\n<p>(Image below)</p>\n</td>\n<td>Normal capillaries in evenly spaced parallel loops</td>\n<td>Distorted capillaries with widened &amp; irregular loops</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/154d53a6118c4185a23957ac0fcb5dcbx1280x2049.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6552",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common histological pattern of interstitial lung disease seen in patients with systemic sclerosis?",
      "choices": [
        {
          "id": 1,
          "text": "Non specific interstitial pneumonia"
        },
        {
          "id": 2,
          "text": "Usual interstitial pneumonia"
        },
        {
          "id": 3,
          "text": "Desquamative interstitial pneumonia"
        },
        {
          "id": 4,
          "text": "Cryptogenic organizing pneumonia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common histological pattern of interstitial lung disease in systemic sclerosis (scleroderma) is&nbsp;<strong>non-specific interstitial pneumonia (NSIP). </strong>It&nbsp;commonly affects the lower lobes and is characterised by ground-glass opacities.</p>\n<p><strong>Note</strong>: Usual interstitial pneumonia (UIP) is the most common type of ILD in rheumatoid arthritis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6549",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs are implicated in systemic sclerosis-like illness?<div class='question-desc-html'><ol>\n<li>Cyclophosphamide</li>\n<li>Pentazocine</li>\n<li>Bosentan</li>\n<li>Bleomycin</li>\n<li>Cocaine</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, and 4"
        },
        {
          "id": 2,
          "text": "2, 3, and 5"
        },
        {
          "id": 3,
          "text": "1, 4, and 5"
        },
        {
          "id": 4,
          "text": "2, 4, and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Drugs implicated in systemic sclerosis-like illness are:</p>\n<ul>\n<li><strong>Bleomycin</strong></li>\n<li><strong>Pentazocine</strong></li>\n<li><strong>Cocaine</strong></li>\n<li>L-tryptophan-containing dietary supplements</li>\n</ul>\n<p>Chemicals implicated in systemic sclerosis-like illness are:</p>\n<ul>\n<li>Heavy metals</li>\n<li>Polyvinyl chloride (PVC)</li>\n<li>Toluene</li>\n<li>Trichloroethylene</li>\n</ul>\n<p><strong>Cyclophosphamide</strong> and <strong>bosentan</strong> are used in the <strong>treatment</strong> of systemic sclerosis (SSc). Cyclophosphamide reduces the progression of <strong>ILD</strong> associated with SSc. Bosentan reduces the risk of new ulcers in <strong>Raynaud's</strong> <strong>phenomenon</strong> associated with SSc.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6545",
      "difficulty": "medium"
    },
    {
      "text": "A 38-year-old woman presents with ulceration over her fingers. She has history of Raynaud's phenomenon and GERD since 3 years. Which of the following can be used as a screening test for her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Antinuclear antibody (ANA)"
        },
        {
          "id": 2,
          "text": "Anti centromere antibody"
        },
        {
          "id": 3,
          "text": "Anti topoisomerase I (Scl-70)"
        },
        {
          "id": 4,
          "text": "Anti-cardiolipin antibody"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The presence of digital ulcers, Raynaud's phenomenon, and GERD are suggestive of <strong>systemic sclerosis</strong> (scleroderma). <strong>Antinuclear antibody</strong> (ANA) is the preferred <strong>screening</strong> test as it is the most <strong>sensitive</strong> test for both limited and diffuse variants of systemic sclerosis.</p>\n<p>Option B: Anti centromere antibody is the most <strong>specific</strong> test for <strong>CREST</strong> syndrome.</p>\n<p>Option C: Anti topoisomerase I (Scl-70) is the most <strong>specific</strong> test for <strong>diffuse cutaneous systemic sclerosis</strong>.</p>\n<p>Option D: Anti-cardiolipin antibody is seen in SLE and APLA syndrome.</p><hr><h3>Related Pearl: Autoantibodies Seen in Autoimmune Diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sj&ouml;gren&rsquo;s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1588",
      "difficulty": "medium"
    },
    {
      "text": "A 47-year-old woman presents with complaints of swollen fingers, heartburn, and occasional joint pains. She gives a history suggestive of Raynaud's phenomenon. Physical examination reveals taut, thickened skin over her hands and fingers with limited mobility. The presence of which of the following antibodies will confirm her diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Antinuclear antibody"
        },
        {
          "id": 2,
          "text": "Anticentromere antibody"
        },
        {
          "id": 3,
          "text": "Anti-topoisomerase I antibody"
        },
        {
          "id": 4,
          "text": "Anti-RNA polymerase III antibody"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario of skin thickening in the hands and fingers (sclerodactyly), Raynaud's phenomenon, heartburn (GERD), and occasional arthralgia is suggestive of&nbsp;<strong>limited cutaneous systemic sclerosis (lcSSc). </strong>The presence&nbsp;of <strong>anticentromere antibody (ACA)</strong> will confirm the diagnosis of limited cutaneous systemic sclerosis<strong>.&nbsp;</strong></p>\n<p><strong>Antinuclear antibody (ANA)</strong>&nbsp;is positive in most cases of systemic sclerosis. The absence of this antibody suggests considering an alternate diagnosis.</p><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4915",
      "difficulty": "medium"
    },
    {
      "text": "A 53-year-old woman presented with thickening of skin over the trunk and proximal parts of the limbs. On workup, her serology was found to be positive for anti-topoisomerase I. Which of the following features is not likely to be associated with her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Severe arthralgia"
        },
        {
          "id": 2,
          "text": "Critical limb ischemia"
        },
        {
          "id": 3,
          "text": "Interstitial lung disease"
        },
        {
          "id": 4,
          "text": "Carpal tunnel syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The presence of skin thickening over the trunk and proximal parts of the limbs along with positive anti-topoisomerase I antibodies is suggestive of <strong>diffuse cutaneous systemic sclerosis </strong>(dcSSc). <strong>Critical limb ischemia</strong> is commonly associated with <strong>limited cutaneous systemic sclerosis</strong> (lcSSc).</p><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6544",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is more common in limited cutaneous systemic sclerosis when compared to diffuse cutaneous systemic sclerosis?",
      "choices": [
        {
          "id": 1,
          "text": "Esophageal dysmotility"
        },
        {
          "id": 2,
          "text": "Myopathy"
        },
        {
          "id": 3,
          "text": "Interstitial lung disease"
        },
        {
          "id": 4,
          "text": "Scleroderma renal crisis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Esophageal dysmotility</strong> is more commonly seen in<strong> limited cutaneous systemic sclerosis </strong>(lcSSc) compared to diffuse cutaneous systemic sclerosis.</p>\n<p><strong>Systemic sclerosis </strong>is divided into two based on the patterns of involvement - <strong>diffuse</strong> and <strong>limited.</strong></p>\n<p>Limited cutaneous systemic sclerosis is characteristically associated with <strong>CREST syndrome, </strong>which includes <strong>c</strong>alcinosis cutis, <strong>R</strong>aynaud&rsquo;s phenomenon, <strong>e</strong>sophageal dysmotility, <strong>s</strong>clerodactyly and<strong> t</strong>elangiectasia.&nbsp;</p>\n<p>Skin involvement, interstitial lung disease (Option C), myopathy (Option B), and scleroderma renal crisis (Option D) are more common in <strong>diffuse cutaneous systemic sclerosis</strong> (dcSSc) than limited cutaneous systemic sclerosis.</p>\n<p>The incidence of ischemic digital ulcers, CREST features, and primary biliary cirrhosis is more in limited cutaneous systemic sclerosis. The frequency of <strong>pulmonary arterial hypertension</strong> (PAH) is <strong>equal</strong> in both types.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9948",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a component of CREST syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Calcinosis cutis"
        },
        {
          "id": 2,
          "text": "Renal failure"
        },
        {
          "id": 3,
          "text": "Esophageal dysmotility"
        },
        {
          "id": 4,
          "text": "Sclerodactyly"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Renal failure is not a component of CREST syndrome.</p>\n<p><strong>CREST syndrome</strong>&nbsp;is seen in limited cutaneous systemic sclerosis (<strong>lcSSc</strong>) and consists of the following:</p>\n<ul>\n<li><strong>C</strong>alcinosis cutis</li>\n<li><strong>R</strong>aynaud&rsquo;s phenomenon</li>\n<li><strong>E</strong>sophageal dysmotility</li>\n<li><strong>S</strong>clerodactyly</li>\n<li><strong>T</strong>elangiectasia</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5b1c8ade86304eecb5d229324d11e418x1280x2560.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6542",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following antibodies is likely to be positive in patients who develop scleroderma renal crisis?",
      "choices": [
        {
          "id": 1,
          "text": "Anti centromere"
        },
        {
          "id": 2,
          "text": "Anti Ku"
        },
        {
          "id": 3,
          "text": "Anti U1-RNP"
        },
        {
          "id": 4,
          "text": "Anti RNA polymerase III"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Anti-RNA polymerase III</strong>&nbsp;antibody is associated with <strong>scleroderma</strong> <strong>renal crisis.</strong></p>\n<p>Scleroderma renal crisis is scleroderma with accelerated <strong>hypertension, acute kidney injury </strong>and<strong> renal failure</strong>. The antibodies associated with&nbsp;it are:</p>\n<ul>\n<li>Anti-RNA polymerase III</li>\n<li>Topoisomerase I</li>\n<li>U3-RNP</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Target Antigen</strong></td>\n<td><strong>Characteristic Clinical Association</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase I</td>\n<td>Early ILD, cardiac involvement, scleroderma renal crisis</td>\n</tr>\n<tr>\n<td>RNA Polymerase III</td>\n<td>Scleroderma renal crisis, increased cancer risk, GAVE (gastric antral vascular ectasia)</td>\n</tr>\n<tr>\n<td>U3-RNP</td>\n<td>PAH, ILD, scleroderma renal crisis, and myositis</td>\n</tr>\n<tr>\n<td>Th/To</td>\n<td>Interstitial lung disease (ILD) and Pulmonary artery hypertension (PAH)</td>\n</tr>\n<tr>\n<td>Ku</td>\n<td>Overlap syndrome</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6547",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man presents to the ER with severe headache, blurring of vision, and oliguria. Examination reveals BP of 200/100mmHg and papilledema. Skin thickening is noted over his hands, with contractures in the wrist and fingers. Investigations reveal serum creatinine of 3mg/dL and peripheral smear shows schistocytes. What is the drug of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Direct renin inhibitors"
        },
        {
          "id": 2,
          "text": "ACE inhibitors"
        },
        {
          "id": 3,
          "text": "Steroids"
        },
        {
          "id": 4,
          "text": "Calcium channel blockers"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>scleroderma renal crisis.&nbsp;</strong>The drug of choice is <strong>ACE inhibitors.&nbsp;</strong></p>\n<p>Scleroderma renal crisis is a medical emergency characterized by acute onset malignant hypertension and kidney failure, usually in the absence of previous evidence of significant kidney disease. The use of <strong>steroids</strong> is associated with an <strong>increased</strong> <strong>risk</strong> of scleroderma renal crisis.</p>\n<p class=\"p1\">Clinical features of scleroderma renal crisis are:</p>\n<ul>\n<li class=\"p1\"><strong>Accelerated hypertension&nbsp;</strong>-&nbsp;headache, vomiting, blurring of vision, hypertensive retinopathy, and hypertensive encephalopathy.</li>\n<li class=\"p1\"><strong>Acute kidney injury</strong> - oliguria, mild proteinuria, microscopic hematuria, renal failure.</li>\n<li class=\"p1\">Pulmonary edema, congestive heart failure.</li>\n<li class=\"p1\">Microangiopathic hemolytic anemia (<strong>schistocytes</strong>), thrombocytopenia.</li>\n</ul>\n<p>In patients with persistent hypertension, the addition of angiotensin II receptor blockers, calcium channel blockers, and direct renin inhibitors should be considered.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6554",
      "difficulty": "medium"
    }
  ]
}